Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. - Wikidata - wikimedia - TriplyDB

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

http://www.wikidata.org/entity/Q36674142

about

Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium Channels Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease Subclinical Alterations of Cardiac Mechanics Present Early in the Course of Pediatric Type 1 Diabetes Mellitus: A Prospective Blinded Speckle Tracking Stress Echocardiography Study.Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet.Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1 Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2+/-) knockout mice.Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.Application of a novel curcumin analog in the management of diabetic cardiomyopathy.Overnutrition, mTOR signaling, and cardiovascular diseases.Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.Do age, diabetes and left ventricular function affect the outcomes of ischemic mitral valve repair?Estrogen and mitochondria function in cardiorenal metabolic syndrome.Complex regulation of PKCβ2 and PDK-1/AKT by ROCK2 in diabetic heart.Body weight in midlife and long-term risk of developing heart failure-a 35-year follow-up of the primary prevention study in Gothenburg, Sweden Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis.Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki rats Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy.Present Insights on Cardiomyopathy in Diabetic Patients.Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes The absence of insulin signaling in the heart induces changes in potassium channel expression and ventricular repolarization.Role of Vitamin D in Uremic Vascular Calcification.Abnormalities of the cardiac stem and progenitor cell compartment in experimental and human diabetes.Examining the Use of Dietary Fiber in Reducing the Risk of Type 2 Diabetes Mellitus in Latino Youth.The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1.Integrins and integrin-related proteins in cardiac fibrosis.Metabolic remodeling in early development and cardiomyocyte maturation.Anti-fibrotic actions of relaxin.Type 2 Diabetes and Heart Failure: Challenges and Solutions.Childhood type 2 diabetes: Risks and complications.Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin-angiotensin system and induction of miR-208a.Inflammation and metabolic cardiomyopathy.Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.

P2860

Q24294870-BD1698BF-C983-4982-9BD8-57BC3388D63B Q26746998-AC2D49F4-C1B6-4187-9B74-7B4254CE5EBC Q26751133-A896D491-1405-4B0D-BA4C-5B72DF67A201 Q26775037-E3C8D8AE-FCBC-4E99-A635-F04FA7AD01A0 Q26798131-7CD478CE-6936-4871-958E-0B8DE0D7198D Q28077454-A4F95D62-9718-4D87-9EC8-88B0C747744D Q30391941-37EA3E29-C086-42D9-B283-57D826B4D78C Q33584753-8E156687-FC36-493D-BE68-F28C90A32D0F Q33816171-4433CBCB-0187-4D8F-B2D7-7F7F52D33BB3 Q33894127-16B3CC72-98AA-4024-8BAA-851AABD425D2 Q34027687-6E54B784-0617-494B-9B17-F597891FE3E6 Q34227841-EEDD0F46-5834-40A1-AFC4-9E5CB5905D26 Q34519316-221D58F7-60F0-40BE-B008-5682A82857A2 Q34797559-B8ABCE15-3AFD-4A89-BAF2-5B3377380175 Q34821448-F53478B5-E2D9-409B-B838-52A6BD853EA2 Q35054122-4E5FC48D-CEAE-457A-BB81-5B86B39F5002 Q35086234-F1B1E13E-4CED-4FC3-9315-EB9C87A9BA4A Q35177204-16AEF8B7-09C1-4F6B-A75B-465B6F07BA20 Q35190449-B1662914-5ABE-4E53-9277-463AD43279A2 Q35667311-198CC96B-8341-4641-8521-FB1ABC247A41 Q35883067-327792B7-FA6D-4805-93F3-96FAC78497FA Q36000073-A4D79DAD-C7B3-4D32-90A7-D2D94AF7BAD7 Q37095161-86846721-66EE-40FE-9DD9-B1C10ED5ADF9 Q37156557-DAD4A796-FE3D-4996-9193-0DE76F9EF960 Q37363507-EB8B9ED0-1263-4F56-93AD-3547BBF895F6 Q37402793-39C5637E-2221-45AE-8F55-35DEE79C8E8F Q37586729-C1104342-A9EA-4BEC-9355-17DCE5AC6C70 Q37629260-EB1684E5-4240-4C9F-9D89-3564A934A5DA Q37670797-38C2C966-9698-4A2B-B7DA-A275E7A62F54 Q38114923-E3674DFA-0555-4204-B7FD-151F168D24CD Q38175004-E2A6C29C-63E9-4812-8924-2B5D1BCE8F77 Q38254130-95961FC5-FC68-4F98-A849-BAD0EDE0B902 Q38631821-C86EA4BD-5FBD-40BD-8698-9AA78815201F Q38748989-C78B25F3-7BAD-446D-B5C6-3922C40E252A Q38850557-BF66A592-4427-49A3-A7C6-F0F818AA14E7 Q38859858-2AC576C2-F142-4169-8079-B38D780A6D3E Q38972330-E684B959-5230-4C5A-8505-2261B937CE3E Q39172914-E0A95B48-4BFF-4C90-9E0C-6347F4BDDC32 Q39232024-47E0F2BE-1571-4B94-98B1-7B4338ACA4EF Q39345477-E8D1471C-3150-435D-9720-8215D2AD9CB2

P2860

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

http://www.wikidata.org/entity/Q36674142

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

@ast

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

@en

type

label

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

@ast

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

@en

prefLabel

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

@ast

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

@en

P1433

Q36674142-A6929E85-A739-4159-A919-A6A77DC39E12

P1476

Q36674142-3E0F1CCF-C5F9-4B68-B27D-39097D875A2E

P2093

Q36674142-01640CC9-464D-4DEF-8821-08AA45D0C982

Q36674142-54B17B30-DA66-4F2C-8941-D2616ACED30E

Q36674142-89998835-D9B9-4B55-A9BD-ADAD3228A749

P2860

Q36674142-025ED4C1-00FC-44B1-BBE4-84C169FC1549

Q36674142-061FE8B5-4D38-4876-B864-E893870CD69C

Q36674142-0837C0CF-8F3C-4125-A3F9-35E10D8073A6

Q36674142-0FCA2A75-9B03-4E22-9019-93BC5BBD0545

Q36674142-1A383377-4EEF-46F3-9028-74569DA29F17

Q36674142-1BD04F25-224B-4495-867D-9D90C1A4EBB8

Q36674142-1D3A2838-2006-45F8-AD34-8831C69FA3EB

Q36674142-1E3DC22D-45A1-45FC-B0E4-A456FFA2766A

Q36674142-21AE1537-BEE3-4670-8F05-0B4718BBA83C

Q36674142-2383CF85-3FF3-4778-BECE-EEED0FF07D6D

P304

Q36674142-624FBF1B-A77D-4BEB-938F-1AF059C4C683

P31

Q36674142-D2102DC6-D074-4505-9D6E-92BFF8C2D59E

P356

Q36674142-24923A8B-6909-4558-A601-2D36673C21A1

P407

Q36674142-800A26C7-57D4-4E9A-85E5-91B843F55E27

P433

Q36674142-E849842E-CA50-485D-9CE9-BCCCFE139ECD

P478

Q36674142-AD66C384-4B13-42F4-9DC2-59919F3F2259

P50

Q36674142-EC037F1E-6E53-499D-8A38-796A387D74B7

P577

Q36674142-8BE630C6-A445-4161-9F4D-75123B7DFB60

P698

Q36674142-843B0862-0EDB-4291-A0E6-6F94CE93AA77

P932

Q36674142-46824C62-9C44-405C-AD99-9D141D557D16

P356

J.LFS.2012.10.028

P1433

P1476

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes

@en

P2093

Annayya R Aroor

http://www.w3.org/2001/XMLSchema#string

Chirag H Mandavia

http://www.w3.org/2001/XMLSchema#string

James R Sowers

http://www.w3.org/2001/XMLSchema#string

P2860

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2

Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

Over-nutrition and metabolic cardiomyopathy

Optimization of cardiac metabolism in heart failure

Signal integration in the endoplasmic reticulum unfolded protein response

Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes

Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.

The Role of Overweight and Obesity in the Cardiorenal Syndrome.

P304

601-608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.LFS.2012.10.028

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P50

Vincent G DeMarco

P577

2012-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23147391

http://www.w3.org/2001/XMLSchema#string

P932

3594135

http://www.w3.org/2001/XMLSchema#string